ClinicalTrials.govpublic full text
A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers
triple-negative breast cancer, squamous cell lung cancer, non-squamous cell lung cancer with kras mutations, non-squamous cell lung cancer with wild-type kras, breast, lung, squamous, kras, azd, selumetinib, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838816
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.